United-guardian ( (UG) ) has released its Q3 earnings. Here is a breakdown of the information United-guardian presented to its investors.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
United-Guardian, Inc., a Delaware-based company, specializes in the manufacturing and marketing of specialty cosmetic ingredients, pharmaceutical products, and medical lubricants, operating primarily through its Guardian Laboratories division. In its latest earnings report for the quarter ending September 30, 2025, United-Guardian reported a decline in net sales to $2.26 million from $3.06 million in the same period last year, with net income also dropping to $268,441 from $865,484. Key financial metrics revealed a decrease in income from operations to $215,072 from $949,128, attributed to lower sales in cosmetic ingredients and increased operating expenses. Despite a challenging quarter, the company maintained a stable financial position with total assets of $12.18 million and retained earnings of $10.12 million. Looking ahead, United-Guardian remains focused on expanding its product lines and navigating global market challenges, including tariffs and supply chain issues, while anticipating the launch of its new Natrajel line in 2026.